TCR-T immunotherapy targeting EBV-associated malignancies

被引：0
|
作者：
Jia, L. [1 ]
Chen, H. [1 ]
Liu, F. [1 ]
Wu, D. [2 ]
Ding, Z. [1 ]
Rui, W. [1 ]
Zhao, X. [1 ]
Chen, W. [2 ]
Lin, X. [1 ]
机构：
[1] Tsinghua Univ, Beijing, Peoples R China
[2] Zhejiang Univ, Hangzhou, Zhejiang, Peoples R China
来源：
EUROPEAN JOURNAL OF IMMUNOLOGY | 2019年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P2286
引用
收藏
页码：1722 / 1722
页数：1
相关论文
共 50 条
  • [41] TCR vaccines for active immunotherapy of T cell malignancies
    Okada, CY
    Wong, CP
    Denney, DW
    Levy, R
    JOURNAL OF IMMUNOLOGY, 1997, 159 (11): : 5516 - 5527
  • [42] Targeting EBV-encoded products: Implications for drug development in EBV-associated diseases
    Lv, Mengwen
    Ding, Yuan
    Zhang, Yan
    Liu, Shuzhen
    REVIEWS IN MEDICAL VIROLOGY, 2024, 34 (01)
  • [43] Perspectives for immunotherapy of EBV-associated GLELC: A relatively "hot" tumor microenvironment
    Lei, Yanna
    Cao, Peng
    Zheng, Xiufeng
    Wei, Jing
    Cheng, Mo
    Liu, Ming
    CANCER MEDICINE, 2023, 12 (19): : 19838 - 19849
  • [44] Harnessing the power of TCR-T cell therapy: A new era in cancer immunotherapy
    Cai, Yuanting
    Zhao, Guo
    Ma, Peiwen
    Fang, Hong
    Dong, Xueyuan
    Wang, Yuning
    Ding, Jiatong
    Wang, Shuhang
    Li, Ning
    CANCER LETTERS, 2025, 613
  • [45] The novel immune landscape of immune-checkpoint blockade in EBV-associated malignancies
    Zhang, Feng
    Li, Wenjing
    Zheng, Xinglong
    Ren, Yinlong
    Li, Lijun
    Yin, Haiyan
    FASEB JOURNAL, 2024, 38 (21):
  • [46] AN ANTIGEN PRESENTING COMPLEX FOR THE GENERATION OF BROAD-SPECIFICITY EFFECTOR T LYMPHOCYTES FOR THE TREATMENT OF EBV-ASSOCIATED MALIGNANCIES
    Ngo, M. C.
    Ando, J.
    Gottschalk, S.
    Bollard, C.
    Heslop, H.
    Rooney, C.
    CYTOTHERAPY, 2013, 15 (04) : S10 - S10
  • [47] Off-the-shelf EBV-specific T cell immunotherapy for rituximab-refractory EBV-associated lymphoma following transplantation
    Prockop, Susan
    Doubrovina, Ekaterina
    Suser, Stephanie
    Heller, Glenn
    Barker, Juliet
    Dahi, Parastoo
    Perales, Miguel A.
    Papadopoulos, Esperanza
    Sauter, Craig
    Castro-Malaspina, Hugo
    Boulad, Farid
    Curran, Kevin J.
    Giralt, Sergio
    Gyurkocza, Boglarka
    Hsu, Katharine C.
    Jakubowski, Ann
    Hanash, Alan M.
    Kernan, Nancy A.
    Kobos, Rachel
    Koehne, Guenther
    Landau, Heather
    Ponce, Doris
    Spitzer, Barbara
    Young, James W.
    Behr, Gerald
    Dunphy, Mark
    Haque, Sofia
    Teruya-Feldstein, Julie
    Arcila, Maria
    Moung, Christine
    Hsu, Susan
    Hasan, Aisha
    O'Reilly, Richard J.
    JOURNAL OF CLINICAL INVESTIGATION, 2020, 130 (02): : 733 - 747
  • [48] Novel insights into TCR-T cell therapy in solid neoplasms: optimizing adoptive immunotherapy
    Weihuan Shao
    Yiran Yao
    Ludi Yang
    Xiaoran Li
    Tongxin Ge
    Yue Zheng
    Qiuyi Zhu
    Shengfang Ge
    Xiang Gu
    Renbing Jia
    Xin Song
    Ai Zhuang
    Experimental Hematology & Oncology, 13
  • [49] Novel insights into TCR-T cell therapy in solid neoplasms: optimizing adoptive immunotherapy
    Shao, Weihuan
    Yao, Yiran
    Yang, Ludi
    Li, Xiaoran
    Ge, Tongxin
    Zheng, Yue
    Zhu, Qiuyi
    Ge, Shengfang
    Gu, Xiang
    Jia, Renbing
    Song, Xin
    Zhuang, Ai
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2024, 13 (01)
  • [50] DONOR T-CELLS TO TREAT EBV-ASSOCIATED LYMPHOMA
    HESLOP, HE
    BRENNER, MK
    ROONEY, CM
    NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (10): : 679 - 680
12345